More about

Walk Test

News
December 13, 2019
1 min read
Save

EMPERIAL top-line results: Empagliflozin for HFpEF, HFrEF fails to improve exercise ability

EMPERIAL top-line results: Empagliflozin for HFpEF, HFrEF fails to improve exercise ability

Boehringer Ingelheim and Eli Lilly and Co. announced negative top-line results for its EMPERIAL-Reduced and EMPERIAL-Preserved trials, nothing that the SGLT2 inhibitor empagliflozin did not meet the primary endpoint of improvements in exercise ability according to the 6-minute walk test from baseline to 12 weeks compared with placebo in patients with chronic HF with reduced and preserved ejection fraction.

News
August 23, 2019
2 min read
Save

High-intensity step training improves walking skills after stroke

Patients with chronic stroke who participated in high-intensity step training had greater improvements in gait symmetry and walking ability compared with those who participated in low-intensity training, according to a study published in Stroke.

View more